Document:

Exhibit 10.6

 

REGISTRATION
RIGHTS AGREEMENT

 

This
Registration Rights Agreement (the “Agreement”) is made and entered into as of this 26th day of December,
2019 by and among Intellisense Solutions Inc., a Nevada corporation (the “Company”) and the “Investors”
named in that certain Securities Purchase Agreement by and among the Company, ScoutCam Ltd. and the Investors (the “Purchase
Agreement”). Capitalized terms used herein have the respective meanings ascribed thereto in the Purchase Agreement unless
otherwise defined herein.

 

The
parties hereby agree as follows:

 

1.       Certain
Definitions.

 

As
used in this Agreement, the following terms shall have the following meanings:

 

“Investors”
means the Investors identified in the Purchase Agreement and any Affiliate or permitted transferee of any Investor who is a subsequent
holder of any Warrants or Registrable Securities.

 

“Prospectus”
means (i) any prospectus (preliminary or final) included in any Registration Statement, as amended or supplemented by any prospectus
supplement, with respect to the terms of the offering of any portion of the Registrable Securities covered by such Registration
Statement and by all other amendments and supplements to the prospectus, including post-effective amendments and all material
incorporated by reference in such prospectus, and (ii) any “free writing prospectus” as defined in Rule 405 under
the Securities Act.

 

“Register,”
“registered” and “registration” refer to a registration made by preparing and filing a Registration
Statement or similar document in compliance with the Securities Act (as defined below), and the declaration or ordering of effectiveness
of such Registration Statement or document.

 

“Registrable
Securities” means (i) the shares of Common Stock issued to the Investors under the Purchase Agreement, (ii) the shares
of Common Stock underline the Warrants issued to the Investors under the Purchase Agreement, and (iii) any other securities issued
or issuable with respect to or in exchange for such shares of Common Stock or the shares of Common Stock underline such Warrants,
whether by merger, charter amendment, or otherwise; provided, that, a security shall cease to be a Registrable Security (and the
Company shall not be required to maintain the effectiveness of any, or file another, Registration Statement hereunder with respect
thereto) for so long as (a) a Registration Statement with respect to the sale of such Registrable Securities is declared effective
by the SEC under the Securities Act, (b) such Registrable Securities have been previously sold in accordance with Rule 144, or
(c) such securities become eligible for resale without volume or manner-of-sale restrictions and without current public information
pursuant to Rule 144 as set forth in a written opinion letter to such effect, addressed, delivered and acceptable to the Transfer
Agent and the affected holders, as reasonably determined by the Company, upon the advice of counsel to the Company and the Transfer
Agent has issued certificates for such Registrable Securities to the holder thereof, or as such holder may direct, without any
restrictive legend.

 

    	 

    	 

    

 

“Registration
Statement” means any registration statement of the Company filed under the Securities Act that covers the resale of
any of the Registrable Securities pursuant to the provisions of this Agreement, amendments and supplements to such Registration
Statement, including post-effective amendments, all exhibits and all material incorporated by reference in such Registration Statement.

 

“Required
Investors” means the Investors beneficially owning a majority of the Registrable Securities (without regard to any exercise
limitations specified in the Warrants).

 

2.       Registration.

 

(a)       Registration
Statement. Promptly following the closing of the purchase and sale of the securities contemplated by the Purchase Agreement
(the “Closing Date”), the Company shall use commercially reasonable efforts to
prepare and file with the SEC, within ninety (90) days after the Closing Date, one Registration
Statement on Form S-1 (or such other form of registration is then available to effect a registration for resale of the Registrable
Securities), covering the resale of the Registrable Securities. Subject to any SEC comments, such Registration Statement
shall include the plan of distribution attached hereto as Exhibit A; provided, however, that no Investor shall be named
as an “underwriter” in the Registration Statement without the Investor’s prior written consent. Such Registration
Statement also shall cover, to the extent allowable under the Securities Act and the rules promulgated thereunder (including Rule
416), such indeterminate number of additional shares of Common Stock resulting from stock splits, stock dividends or similar transactions
with respect to the Registrable Securities. Such Registration Statement shall not include any shares of Common Stock or other
securities for the account of any other holder without the prior written consent of the Required Investors. The Registration Statement
(and each amendment or supplement thereto, and each request for acceleration of effectiveness thereof) shall be provided in accordance
with Section 3(c) to the Investors and their counsel prior to its filing or other submission.

 

(b)       Expenses.
The Company will pay all expenses associated with effecting the registration of the Registrable Securities, including filing and
printing fees, the Company’s counsel and accounting fees and expenses, costs associated with clearing the Registrable Securities
for sale under applicable state securities laws, and listing fees, but excluding discounts, commissions, fees of underwriters,
selling brokers, dealer managers or similar securities industry professionals with respect to the Registrable Securities being
sold or any fees or any of the Investor’s counsel.

 

(c)       Effectiveness.

 

(i)       The
Company shall use commercially reasonable efforts to have any Registration Statement declared effective as soon as practicable.
The Company shall notify the Investors by facsimile or e-mail as promptly as practicable, and in any event, within twenty-four
(24) hours, after any Registration Statement is declared effective and shall simultaneously provide the Investors with copies
of any related Prospectus to be used in connection with the sale or other disposition of the securities covered thereby.

 

    	 

    	 

    

 

(ii)       For
not more than thirty (30) consecutive days or for a total of not more than sixty (60) days in any twelve (12) month period, the
Company may suspend the use of any Prospectus included in any Registration Statement contemplated by this Section in the event
that the Company determines in good faith that such suspension is necessary to (A) delay the disclosure of material non-public
information concerning the Company, the disclosure of which at the time is not, in the good faith opinion of the Company, in the
best interests of the Company or (B) amend or supplement the affected Registration Statement or the related Prospectus so that
such Registration Statement or Prospectus shall not include an untrue statement of a material fact or omit to state a material
fact required to be stated therein or necessary to make the statements therein, in the case of the Prospectus in light of the
circumstances under which they were made, not misleading (an “Allowed Delay”); provided, that the Company shall promptly
(a) notify each Investor in writing of the commencement of an Allowed Delay, but shall not (without the prior written consent
of an Investor) disclose to such Investor any material non-public information giving rise to an Allowed Delay, (b) advise the
Investors in writing to cease all sales under the Registration Statement until the end of the Allowed Delay and (c) use commercially
reasonable efforts to terminate an Allowed Delay as promptly as practicable.

 

(d)       Rule
415; Cutback To the extent applicable, if at any time the SEC takes the position that the offering of some or all of the Registrable
Securities in a Registration Statement is not eligible to be made on a delayed or continuous basis under the provisions of Rule
415 under the Securities Act or requires any Investor to be named as an “underwriter”, the Company shall use its best
efforts to persuade the SEC that the offering contemplated by a Registration Statement is a bona fide secondary offering and not
an offering “by or on behalf of the issuer” as defined in Rule 415 and that none of the Investors is an “underwriter”.
The Investors shall have the right to participate or have their counsel participate in any meetings or discussions with the SEC
regarding the SEC’s position and to comment or have their counsel comment on any written submission made to the SEC with
respect thereto. No such written submission shall be made to the SEC to which the Investors’ counsel reasonably objects.
In the event that, despite the Company’s best efforts and compliance with the terms of this Section 2(d), the SEC refuses
to alter its position, the Company shall (i) remove from the Registration Statement such portion of the Registrable Securities
(the “Cut Back Shares”) and/or (ii) agree to such restrictions and limitations on the registration and resale of the
Registrable Securities as the SEC may require to assure the Company’s compliance with the requirements of Rule 415 (collectively,
the “SEC Restrictions”); provided, however, that the Company shall not agree to name any Investor as an “underwriter”
in such Registration Statement without the prior written consent of such Investor. Any cut-back imposed on the Investors pursuant
to this Section 2(d) shall be allocated among the Investors on a pro rata basis, unless the SEC Restrictions otherwise require
or provide or the Investors otherwise agree. No liquidated damages shall accrue as to any Cut Back Shares until such date as the
Company is able to effect the registration of such Cut Back Shares in accordance with any SEC Restrictions (such date, the “Restriction
Termination Date” of such Cut Back Shares). From and after the Restriction Termination Date applicable to any Cut Back Shares,
all of the provisions of this Section 2 (including the liquidated damages provisions) shall again be applicable to such Cut Back
Shares.

 

3.       Company
Obligations. The Company will use commercially reasonable efforts to effect the registration of the Registrable Securities
in accordance with the terms hereof, and pursuant thereto the Company will, as expeditiously as possible:

 

    	 

    	 

    

 

(a)       use
commercially reasonable efforts to cause such Registration Statement to become effective and to remain continuously effective
for a period that will terminate upon the earlier of (i) the date on which all Registrable Securities covered by such Registration
Statement as amended from time to time, have been sold or otherwise disposed of pursuant to the Registration Statement or in a
transaction in which the transferee receives freely tradable shares, (ii) the date on which the Registrable Securities no longer
constitute “Registrable Securities” pursuant to the definition thereof, and (iii) the third anniversary of the closing
date of the Purchase Agreement (the “Effectiveness Period”) and advise the Investors in writing when the Effectiveness
Period has expired;

 

(b)       prepare
and file with the SEC such amendments and post-effective amendments to the Registration Statement and the Prospectus as may be
necessary to keep the Registration Statement effective for the Effectiveness Period and to comply with the provisions of the Securities
Act and the Exchange Act with respect to the distribution of all of the Registrable Securities covered thereby;

 

(c)       provide
copies to and permit counsel designated by the Investors to review each Registration Statement and all amendments and supplements
thereto no fewer than seven (7) days prior to their filing with the SEC and not file any document to which such counsel reasonably
objects;

 

(d)       furnish
to the Investors and their legal counsel (i) promptly after the same is prepared and publicly distributed, filed with the SEC,
or received by the Company (but not later than two (2) Business Days after the filing date, receipt date or sending date, as the
case may be) one (1) copy of any Registration Statement and any amendment thereto, each preliminary prospectus and Prospectus
and each amendment or supplement thereto, and each letter written by or on behalf of the Company to the SEC or the staff of the
SEC, and each item of correspondence from the SEC or the staff of the SEC, in each case relating to such Registration Statement
(other than any portion thereof which contains information for which the Company has sought confidential treatment), and (ii)
such number of copies of a Prospectus, including a preliminary prospectus, and all amendments and supplements thereto and such
other documents as each Investor may reasonably request in order to facilitate the disposition of the Registrable Securities owned
by such Investor that are covered by the related Registration Statement;

 

(e)       use
commercially reasonable efforts to (i) prevent the issuance of any stop order or other suspension of effectiveness and, (ii) if
such order is issued, obtain the withdrawal of any such order at the earliest possible moment;

 

(f)       prior
to any public offering of Registrable Securities, use commercially reasonable efforts to register or qualify or cooperate with
the Investors and their counsel in connection with the registration or qualification of such Registrable Securities for offer
and sale under the securities or blue sky laws of such jurisdictions requested by the Investors and do any and all other commercially
reasonable acts or things necessary or advisable to enable the distribution in such jurisdictions of the Registrable Securities
covered by the Registration Statement; provided, however, that the Company shall not be
required in connection therewith or as a condition thereto to (i) qualify to do business in any jurisdiction where it would not
otherwise be required to qualify but for this Section 3(f), (ii) subject itself to general taxation in any jurisdiction where
it would not otherwise be so subject but for this Section 3(f), or (iii) file a general consent to service of process in any such
jurisdiction;

 

    	 

    	 

    

 

(g)       use
commercially reasonable efforts to cause all Registrable Securities covered by a Registration Statement to be listed on each securities
exchange, interdealer quotation system or other market on which similar securities issued by the Company are then listed;

 

(h)       immediately
notify the Investors, at any time prior to the end of the Effectiveness Period, upon discovery that, or upon the happening of
any event as a result of which, the Prospectus includes an untrue statement of a material fact or omits to state any material
fact required to be stated therein or necessary to make the statements therein not misleading in light of the circumstances then
existing, and promptly prepare, file with the SEC and furnish to such holder a supplement to or an amendment of such Prospectus
as may be necessary so that such Prospectus shall not include an untrue statement of a material fact or omit to state a material
fact required to be stated therein or necessary to make the statements therein not misleading in light of the circumstances then
existing;

 

(i)       otherwise
use commercially reasonable efforts to comply with all applicable rules and regulations of the SEC under the Securities Act and
the Exchange Act; and

 

(j)       With
a view to making available to the Investors the benefits of Rule 144 (or its successor rule) and any other rule or regulation
of the SEC that may at any time permit the Investors to sell shares of Common Stock to the public without registration, the Company
covenants and agrees to: (i) make and keep public information available, as those terms are understood and defined in Rule 144,
until the earlier of (A) six months after such date as all of the Registrable Securities may be sold without restriction by the
holders thereof pursuant to Rule 144 or any other rule of similar effect or (B) such date as all of the Registrable Securities
shall have been resold pursuant to a Registration Statement, Rule 144 or otherwise in a transaction in which the transferee receives
freely tradable shares; (ii) file with the SEC in a timely manner all reports and other documents required of the Company under
the Exchange Act; and (iii) furnish to each Investor upon request, as long as such Investor owns any Registrable Securities, (A)
a written statement by the Company that it has complied with the reporting requirements of the Exchange Act, (B) a copy of the
Company’s most recent Annual Report on Form 10-K or Quarterly Report on Form 10-Q, and (C) such other information as may
be reasonably requested in order to avail such Investor of any rule or regulation of the SEC that permits the selling of any such
Registrable Securities without registration.

 

4.       Obligations
of the Investors.

 

(a)       Each
Investor shall furnish in writing to the Company such information regarding itself, the Registrable Securities held by it and
the intended method of disposition of the Registrable Securities held by it, as shall be reasonably required to effect the registration
of such Registrable Securities and shall execute such documents in connection with such registration as the Company may reasonably
request. At least five (5) Business Days prior to the first anticipated filing date of any Registration Statement, the Company
shall notify each Investor of the information the Company requires from such Investor if such Investor elects to have any of the
Registrable Securities included in the Registration Statement. An Investor shall provide such information to the Company at least
two (2) Business Days prior to the first anticipated filing date of such Registration Statement if such Investor elects to have
any of the Registrable Securities included in the Registration Statement.

 

    	 

    	 

    

 

(b)       Each
Investor, by its acceptance of the Registrable Securities agrees to cooperate with the Company as reasonably requested by the
Company in connection with the preparation and filing of a Registration Statement hereunder, unless such Investor has notified
the Company in writing of its election to exclude all of its Registrable Securities from such Registration Statement.

 

(c)       Each
Investor agrees that, upon receipt of any notice from the Company of either (i) the commencement of an Allowed Delay pursuant
to Section 2(c)(ii) or (ii) the happening of an event pursuant to Section 3(h) hereof, such Investor will immediately discontinue
disposition of Registrable Securities pursuant to the Registration Statement covering such Registrable Securities, until the Investor
is advised by the Company that such dispositions may again be made.

 

(d)       Each
Investor agrees that it will not sell, dispose or otherwise transfer its Registrable Securities other than (i) pursuant to the
Plan of Distribution contained in the Registration Statement covering such Registrable Securities, (ii) in accordance with the
requirements of Rule 144 or (iii) in a transaction exempt from the registration requirements of the Securities Act and as to which
the Company has received an opinion of counsel reasonably satisfactory to it that such transfer may lawfully be made without registration
under the Securities Act.

 

5.       Indemnification.

 

(a)       Indemnification
by the Company. The Company will indemnify and hold harmless each Investor and its officers, directors, members, managers,
partners, trustees, employees and agents and other representatives, successors and assigns, and each other person, if any, who
controls such Investor within the meaning of the Securities Act, against any losses, claims, damages or liabilities, joint or
several, to which they may become subject under the Securities Act or otherwise, insofar as such losses, claims, damages or liabilities
(or actions in respect thereof) arise out of or are based upon: (i) any untrue statement or alleged untrue statement or omission
or alleged omission of any material fact contained in any registration statement, any prospectus, or any amendment or supplement
thereof; (ii) any blue sky application or other document executed by the Company specifically for that purpose or based upon written
information furnished by the Company filed in any state or other jurisdiction in order to qualify any or all of the Registrable
Securities under the securities laws thereof (any such application, document or information herein called a “Blue Sky Application”);
(iii) the omission or alleged omission to state in a Blue Sky Application a material fact required to be stated therein or necessary
to make the statements therein not misleading; (iv) any violation by the Company or its agents of any rule or regulation promulgated
under the Securities Act applicable to the Company or its agents and relating to action or inaction required of the Company in
connection with such registration; or (v) any failure to register or qualify the Registrable Securities included in any such Registration
Statement in any state where the Company or its agents has affirmatively undertaken or agreed in writing that the Company will
undertake such registration or qualification on an Investor’s behalf and will reimburse such Investor, and each such officer,
director or member and each such controlling person for any legal or other expenses reasonably incurred by them in connection
with investigating or defending any such loss, claim, damage, liability or action; provided, however, that the Company
will not be liable in any such case if and to the extent that any such loss, claim, damage or liability arises out of or is based
upon an untrue statement or alleged untrue statement or omission or alleged omission so made in conformity with information furnished
by such Investor or any such controlling person in writing specifically for use in such registration statement or prospectus.

 

    	 

    	 

    

 

(b)       Indemnification
by the Investors. Each Investor agrees, severally but not jointly, to indemnify and hold harmless, to the fullest extent permitted
by law, the Company, its directors, officers, employees, stockholders and each person who controls the Company (within the meaning
of the Securities Act) against any losses, claims, damages, liabilities and expense (including reasonable attorney fees) resulting
from any untrue statement of a material fact or any omission of a material fact required to be stated in the Registration Statement
or Prospectus or amendment or supplement thereto or necessary to make the statements therein not misleading, to the extent, but
only to the extent that such untrue statement or omission is contained in any information furnished in writing by such Investor
to the Company specifically for inclusion in such Registration Statement or Prospectus or amendment or supplement thereto. In
no event shall the liability of an Investor be greater in amount than the dollar amount of the proceeds (net of all expenses paid
by such Investor in connection with any claim relating to this Section 6 and the amount of any damages such Investor has otherwise
been required to pay by reason of such untrue statement or omission) received by such Investor upon the sale of the Registrable
Securities included in the Registration Statement giving rise to such indemnification obligation.

 

(c)       Conduct
of Indemnification Proceedings. Any person entitled to indemnification hereunder shall (i) give prompt notice to the indemnifying
party of any claim with respect to which it seeks indemnification and (ii) permit such indemnifying party to assume the defense
of such claim with counsel reasonably satisfactory to the indemnified party; provided that any person entitled to indemnification
hereunder shall have the right to employ separate counsel and to participate in the defense of such claim, but the fees and expenses
of such counsel shall be at the expense of such person unless (a) the indemnifying party has agreed to pay such fees or expenses,
or (b) the indemnifying party shall have failed to assume the defense of such claim and employ counsel reasonably satisfactory
to such person or (c) in the reasonable judgment of any such person, based upon written advice of its counsel, a conflict of interest
exists between such person and the indemnifying party with respect to such claims (in which case, if the person notifies the indemnifying
party in writing that such person elects to employ separate counsel at the expense of the indemnifying party, the indemnifying
party shall not have the right to assume the defense of such claim on behalf of such person); and provided, further,
that the failure of any indemnified party to give notice as provided herein shall not relieve the indemnifying party of its obligations
hereunder, except to the extent that such failure to give notice shall materially adversely affect the indemnifying party in the
defense of any such claim or litigation. It is understood that the indemnifying party shall not, in connection with any proceeding
in the same jurisdiction, be liable for fees or expenses of more than one separate firm of attorneys at any time for all such
indemnified parties. No indemnifying party will, except with the consent of the indemnified party, consent to entry of any judgment
or enter into any settlement that does not include as an unconditional term thereof the giving by the claimant or plaintiff to
such indemnified party of a release from all liability in respect of such claim or litigation.

 

    	 

    	 

    

 

(d)       Contribution.
If for any reason the indemnification provided for in the preceding paragraphs (a) and (b) is unavailable to an indemnified party
or insufficient to hold it harmless, other than as expressly specified therein, then the indemnifying party shall contribute to
the amount paid or payable by the indemnified party as a result of such loss, claim, damage or liability in such proportion as
is appropriate to reflect the relative fault of the indemnified party and the indemnifying party, as well as any other relevant
equitable considerations. No person guilty of fraudulent misrepresentation within the meaning of Section 11(f) of the Securities
Act shall be entitled to contribution from any person not guilty of such fraudulent misrepresentation. In no event shall the contribution
obligation of a holder of Registrable Securities be greater in amount than the dollar amount of the proceeds (net of all expenses
paid by such holder in connection with any claim relating to this Section 6 and the amount of any damages such holder has otherwise
been required to pay by reason of such untrue or alleged untrue statement or omission or alleged omission) received by it upon
the sale of the Registrable Securities giving rise to such contribution obligation.

 

6.       Miscellaneous.

 

(a)       Amendments
and Waivers. Any term of this Agreement may be amended and the observance of any term of this Agreement may be waived (either
generally or in a particular instance and either retroactively or prospectively), only with the written consent of the Company
and the Required Investors.

 

(b)       Notices.
All notices and other communications provided for or permitted hereunder shall be made as set forth in Section 9.4 of the Purchase
Agreement.

 

(c)       Assignments
and Transfers by Investors. The provisions of this Agreement shall be binding upon and inure to the benefit of the Investors
and their respective successors and assigns. An Investor may transfer or assign, in whole or from time to time in part, to one
or more persons its rights hereunder in connection with the transfer of Registrable Securities by such Investor to such person,
provided that such Investor complies with all laws applicable thereto and provides written notice of assignment to the Company
promptly after such assignment is effected.

 

(d)       Assignments
and Transfers by the Company. This Agreement may not be assigned by the Company (whether by operation of law or otherwise)
without the prior written consent of the Required Investors; provided, however, that in the event that the Company is a
party to a merger, consolidation, share exchange or similar business combination transaction in which the Common Stock is converted
into the equity securities of another Person, from and after the effective time of such transaction, such Person shall, by virtue
of such transaction, be deemed to have assumed the obligations of the Company hereunder, the term “Company” shall
be deemed to refer to such Person and the term “Registrable Securities” shall be deemed to include the securities
received by the Investors in connection with such transaction unless such securities are otherwise freely tradable by the Investors
after giving effect to such transaction.

 

(e)       Benefits
of the Agreement. The terms and conditions of this Agreement shall inure to the benefit of and be binding upon the respective
successors and permitted assigns of the parties. Nothing in this Agreement, express or implied, is intended to confer upon any
party other than the parties hereto or their respective successors and permitted assigns any rights, remedies, obligations, or
liabilities under or by reason of this Agreement, except as expressly provided in this Agreement.

 

    	 

    	 

    

 

(f)       Counterparts;
Faxes. This Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of which
together shall constitute one and the same instrument. This Agreement may be delivered via facsimile or other form of electronic
communication, which shall be deemed an original.

 

(g)       Titles
and Subtitles. The titles and subtitles used in this Agreement are used for convenience only and are not to be considered
in construing or interpreting this Agreement.

 

(h)       Severability.
Any provision of this Agreement that is prohibited or unenforceable in any jurisdiction shall, as to such jurisdiction, be ineffective
to the extent of such prohibition or unenforceability without invalidating the remaining provisions hereof but shall be interpreted
as if it were written so as to be enforceable to the maximum extent permitted by applicable law, and any such prohibition or unenforceability
in any jurisdiction shall not invalidate or render unenforceable such provision in any other jurisdiction. To the extent permitted
by applicable law, the parties hereby waive any provision of law which renders any provisions hereof prohibited or unenforceable
in any respect.

 

(i)       Further
Assurances. The parties shall execute and deliver all such further instruments and documents and take all such other actions
as may reasonably be required to carry out the transactions contemplated hereby and to evidence the fulfillment of the agreements
herein contained.

 

(j)       Entire
Agreement. This Agreement is intended by the parties as a final expression of their agreement and intended to be a complete
and exclusive statement of the agreement and understanding of the parties hereto in respect of the subject matter contained herein.
This Agreement supersedes all prior agreements and understandings between the parties with respect to such subject matter.

 

(k)       Governing
Law; Consent to Jurisdiction; Waiver of Jury Trial. This Agreement shall be governed by, and construed in accordance with,
the internal laws of the State of New York without regard to the choice of law principles thereof. Each of the parties hereto
irrevocably submits to the exclusive jurisdiction of the courts of the State of New York located in New York County and the United
States District Court for the Southern District of New York for the purpose of any suit, action, proceeding or judgment relating
to or arising out of this Agreement and the transactions contemplated hereby. Service of process in connection with any such suit,
action or proceeding may be served on each party hereto anywhere in the world by the same methods as are specified for the giving
of notices under this Agreement. Each of the parties hereto irrevocably consents to the jurisdiction of any such court in any
such suit, action or proceeding and to the laying of venue in such court. Each party hereto irrevocably waives any objection to
the laying of venue of any such suit, action or proceeding brought in such courts and irrevocably waives any claim that any such
suit, action or proceeding brought in any such court has been brought in an inconvenient forum. EACH OF THE PARTIES HERETO
WAIVES ANY RIGHT TO REQUEST A TRIAL BY JURY IN ANY LITIGATION WITH RESPECT TO OR ARISING OUT OF THIS AGREEMENT OR THE TRANSACTIONS
CONTEMPLATED HEREBY AND REPRESENTS THAT COUNSEL HAS BEEN CONSULTED SPECIFICALLY AS TO THIS WAIVER.

 

    	 

    	 

    

 

IN
WITNESS WHEREOF, the parties have executed this Agreement or caused their duly authorized officers to execute this Agreement as
of the date first above written.

 

	The Company:	INTELLISENSE SOLUTIONS INC.
	 	 	 
	 	By: 	             
	 	Name:	
	 	Title:	
	 	 	 
	Investor:	[________________________________________]
	 	 	 
	 	By:	                                                            
	 	Name:	 
	 	Title:	 

  

    	 

    	 

    

 

Exhibit
A

 

Plan
of Distribution

 

The
selling stockholders, which as used herein includes donees, pledgees, transferees or other successors-in-interest selling shares
of common stock or interests in shares of common stock received after the date of this prospectus from a selling stockholder as
a gift, pledge, partnership distribution or other transfer, may, from time to time, sell, transfer or otherwise dispose of any
or all of their shares of common stock or interests in shares of common stock on any stock exchange, market or trading facility
on which the shares are traded or in private transactions. These dispositions may be at fixed prices, at prevailing market prices
at the time of sale, at prices related to the prevailing market price, at varying prices determined at the time of sale, or at
negotiated prices.

 

The
selling stockholders may use any one or more of the following methods when disposing of shares or interests therein:

 

	 	–	ordinary brokerage
    transactions and transactions in which the broker-dealer solicits purchasers;
	 	 	 
	 	–	block trades in which
    the broker-dealer will attempt to sell the shares as agent, but may position and resell a portion of the block as principal
    to facilitate the transaction;
	 	 	 
	 	– 	purchases by a broker-dealer
    as principal and resale by the broker-dealer for its account;
	 	 	 
	 	– 	an exchange distribution
    in accordance with the rules of the applicable exchange;
	 	 	 
	 	– 	privately negotiated
    transactions;
	 	 	 
	 	– 	short sales effected
    after the date the registration statement of which this Prospectus is a part is declared effective by the SEC;
	 	 	 
	 	– 	through the writing
    or settlement of options or other hedging transactions, whether through an options exchange or otherwise;
	 	 	 
	 	– 	broker-dealers may
    agree with the selling stockholders to sell a specified number of such shares at a stipulated price per share;
	 	 	 
	 	– 	a combination of any
    such methods of sale; and
	 	 	 
	 	– 	any other method permitted
    by applicable law.

 

The
selling stockholders may, from time to time, pledge or grant a security interest in some or all of the shares of common stock
owned by them and, if they default in the performance of their secured obligations, the pledgees or secured parties may offer
and sell the shares of common stock, from time to time, under this prospectus, or under an amendment to this prospectus under
Rule 424(b)(3) or other applicable provision of the Securities Act amending the list of selling stockholders to include the pledgee,
transferee or other successors in interest as selling stockholders under this prospectus. The selling stockholders also may transfer
the shares of common stock in other circumstances, in which case the transferees, pledgees or other successors in interest will
be the selling beneficial owners for purposes of this prospectus.

 

    	 

    	 

    

 

In
connection with the sale of our common stock or interests therein, the selling stockholders may enter into hedging transactions
with broker-dealers or other financial institutions, which may in turn engage in short sales of the common stock in the course
of hedging the positions they assume. The selling stockholders may also sell shares of our common stock short and deliver these
securities to close out their short positions, or loan or pledge the common stock to broker-dealers that in turn may sell these
securities. The selling stockholders may also enter into option or other transactions with broker-dealers or other financial institutions
or the creation of one or more derivative securities which require the delivery to such broker-dealer or other financial institution
of shares offered by this prospectus, which shares such broker-dealer or other financial institution may resell pursuant to this
prospectus (as supplemented or amended to reflect such transaction).

 

The
aggregate proceeds to the selling stockholders from the sale of the common stock offered by them will be the purchase price of
the common stock less discounts or commissions, if any. Each of the selling stockholders reserves the right to accept and, together
with their agents from time to time, to reject, in whole or in part, any proposed purchase of common stock to be made directly
or through agents. We will not receive any of the proceeds from this offering.

 

The
selling stockholders also may resell all or a portion of the shares in open market transactions in reliance upon Rule 144 under
the Securities Act of 1933, provided that they meet the criteria and conform to the requirements of that rule.

 

The
selling stockholders and any underwriters, broker-dealers or agents that participate in the sale of the common stock or interests
therein may be “underwriters” within the meaning of Section 2(11) of the Securities Act. Any discounts, commissions,
concessions or profit they earn on any resale of the shares may be underwriting discounts and commissions under the Securities
Act. Selling stockholders who are “underwriters” within the meaning of Section 2(11) of the Securities Act will be
subject to the prospectus delivery requirements of the Securities Act.

 

To
the extent required, the shares of our common stock to be sold, the names of the selling stockholders, the respective purchase
prices and public offering prices, the names of any agents, dealer or underwriter, any applicable commissions or discounts with
respect to a particular offer will be set forth in an accompanying prospectus supplement or, if appropriate, a post-effective
amendment to the registration statement that includes this prospectus.

 

In
order to comply with the securities laws of some states, if applicable, the common stock may be sold in these jurisdictions only
through registered or licensed brokers or dealers. In addition, in some states the common stock may not be sold unless it has
been registered or qualified for sale or an exemption from registration or qualification requirements is available and is complied
with.

 

    	 

    	 

    

 

We
have advised the selling stockholders that the anti-manipulation rules of Regulation M under the Exchange Act may apply to sales
of shares in the market and to the activities of the selling stockholders and their affiliates. In addition, to the extent applicable
we will make copies of this prospectus (as it may be supplemented or amended from time to time) available to the selling stockholders
for the purpose of satisfying the prospectus delivery requirements of the Securities Act. The selling stockholders may indemnify
any broker-dealer that participates in transactions involving the sale of the shares against certain liabilities, including liabilities
arising under the Securities Act.

 

We
have agreed to indemnify the selling stockholders against liabilities, including liabilities under the Securities Act and state
securities laws, relating to the registration of the shares offered by this prospectus.

 

We
have agreed with the selling stockholders to keep the registration statement of which this prospectus constitutes a part effective
until the earlier of (i) the date that such securities become eligible for resale without volume or manner-of-sale restrictions
and without current public information pursuant to Rule 144 and certain other conditions have been satisfied, or (ii) all of the
securities have been sold or otherwise disposed of pursuant to the registration statement of which this prospectus forms a part
or in a transaction in which the transferee receives freely tradable shares.Exhibit
10.7

 

CERTAIN IDENTIFIED INFORMATION HAS BEEN
EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS BOTH (i) NOT MATERIAL AND (ii) WOULD LIKELY CAUSE COMPETITIVE HARM TO THE REGISTRANT
IF PUBLICLY DISCLOSED. OMISSIONS ARE DENOTED IN BRACKETS THROUGHOUT THIS EXHIBIT.

 

AMENDED
AND RESTATED ASSET TRANSFER AGREEMENT

 

THIS
AMENDED AND RESTATED ASSET TRANSFER AGREEMENT, dated as of December 1, 2019 (the “Agreement”), effective
as of March 1, 2019 (the “Effective Date”) is entered into by and between ScoutCam Ltd., a company organized
under the laws of the State of Israel (the “Transferee”), and Medigus Ltd., a company organized under the laws
of the State of Israel (“Transferor”). The Transferee and Transferor are referred to hereunder as the “Parties”,
and each of them individually as a “Party”.

 

W
I T N E S S E T H:

 

	WHEREAS	the
    Transferor and Transferee have previously entered into an Asset Transfer Agreement, dated as of March 1, 2019 (the “Prior
    Agreement”); and 
	 	 
	WHEREAS	the
    Parties wish to treat such Prior Agreement as null and void and to replace the Prior Agreement with the Agreement in all respects;
    and
	 	 
	WHEREAS	the
    Agreement does not provide for transfer of any IIA funded know-how, patents or intellectual property of any kind; and 
	 	 
	WHEREAS	the
    Transferor has developed a miniature video technology, referred to as ScoutCamTM; and 
	 	 
	WHEREAS	the
    Board of Directors of the Transferor has caused the formation of the Transferee and has decided that Transferee shall engage
    in the Transferee’s Business (as defined below); and
	 	 
	WHEREAS	Transferor
    desires to transfer and assign to the Transferee, and the Transferee desires to assume from the Transferor, the Transferred
    Assets and Assumed Liabilities (as defined below), all as more specifically provided herein and upon the terms and subject
    to the conditions set forth herein.

 

NOW,
THEREFORE in consideration of the premises and the mutual representations, warranties, covenants and agreements hereinafter set
forth, the parties hereby agree as follows:

 

1.
DEFINITIONS

 

1.1.
Certain Definitions. For purposes of this Agreement, the following terms shall have the meanings specified in this Section
‎1.1:

 

1.1.1.
“Affiliate” means, with respect to any Person, any other Person that, directly or indirectly through one or
more intermediaries, controls, or is controlled by, or is under common control with, such Person, and the term “control”
(including the terms “controlled by” and “under common control with”) means the possession, directly or
indirectly, of the power to direct or cause the direction of the management and policies of such Person, whether through ownership
of voting securities, by contract or otherwise. For purposes of this Agreement, Transferor and Transferee shall not be deemed
Affiliates of one another.

 

1.1.2.
“Documents” means all files, documents, instruments, correspondence, papers, books, reports, records, tapes,
microfilms, photographs, letters, e-mails archives (solely of Employees and consultants), budgets, forecasts, ledgers, journals,
customer lists, customer files, supplier lists, regulatory filings, operating data and plans, technical documentation (design
specifications, functional requirements, operating instructions, logic manuals, flow charts, etc.), user documentation (installation
guides, user manuals, training materials, release notes, working papers, etc.), marketing and advertising documentation (sales
brochures, flyers, pamphlets, promotional materials, web pages, etc.), and other similar materials, in each case in whatever form,
including electronic databases, printed and other electronic media.

 

1.1.3.
“Governmental Body” means any: (a) nation, principality, state, commonwealth, province, territory, county,
municipality, district or other jurisdiction of any nature, (b) federal, state, local, municipal, foreign or other government,
(c) governmental, quasi-governmental or regulatory body of any nature, including any governmental division, subdivision, department,
agency, bureau, branch, office, commission, council, board, instrumentality, organization, unit, or body, (d) court, public or
private arbitrator or other public tribunal or (e) fiscal, revenue, customs or excise authority, body, agency or official.

 

    	 

    	 

    

 

1.1.4.
“IIA” means the Israeli Innovation Authority of the Ministry of Economy and Industry of the State of Israel
(formerly known as the Office of the Chief Scientist).

 

1.1.5.
“Law” means any federal, state, local, municipal, foreign or other law (including common law), statute, legislation,
constitution, code, order, edict, decree, proclamation, treaty, convention, directive, ordinance, rule, regulation, permit, ruling,
determination, decision, interpretation or other requirement that is issued, enacted, adopted, passed, approved, promulgated,
implemented or otherwise put into effect by or under the authority of any Governmental Body and is applicable to and binding upon
the relevant Person.

 

1.1.6.
“Lien” means any lien, pledge, security interest, charge, impairment of title, right of first refusal or other
rights granted or created by the Transferor or any of its Subsidiaries to third parties (other than licenses or rights of use
in the ordinary course of business), it being clarified that when referring to a right of use or license from a third party, “Lien”
shall only refer to the right of use or license and not to the underlying asset or right.

 

1.1.7.
“Person” means (whether or not a capitalized term) any individual, corporation, partnership, limited liability
company, firm, joint venture, association, joint-stock company, trust, estate, unincorporated organization, Governmental Body
or other entity, including any party to this Agreement.

 

1.1.8.
“Representative(s)” means, with respect to any Person, such Person’s Affiliates and the respective directors,
officers, employees, agents, consultants, advisors and other representatives, including legal counsel, accountants and financial
advisors of such Person and its Affiliates, and the successors and assigns of any of the foregoing.

 

1.1.9.
“Transferee’s Business” means certain of the operations and activities currently conducted by the Transferor,
including the research, development, marketing, sale, distribution and maintenance of, and the provision of services for, the
products, applications, technologies or solutions, relating to the miniature video technology, referred to as ScoutCamTM
(the “Products”).

 

2.
TRANSFER OF ASSETS; ASSUMPTION OF LIABILITIES

 

2.1.
Transfer of Assets. On the terms and subject to the conditions set forth in this Agreement, at the Closing, the Transferor
shall transfer, assign, convey and deliver to the Transferee and the Transferee shall accept and assume from the Transferor, all
of the Transferor’s rights, titles and interests in, to and under the transferred assets listed on Schedule ‎2.1 (the
“Transferred Assets”), free and clear of any Liens.

 

The
Transferred Assets shall include, in addition to the assets listed on Schedule ‎2.1:

 

2.1.1.
all rights and title to the severance funds maintained for or on behalf of the Transferred Employees;

 

2.1.2.
all past, present and future causes of action and other enforcement rights primarily under, or on account of, the Transferee’s
Business, the Products or any of the Transferred Assets, including, without limitation, all causes of action and other enforcement
rights for damages, profits, royalties or other payments, injunctive relief, and any other remedies of any kind for past, current
and future infringement, misappropriation or any violations of any one of the rights embodied in any of the Transferred Assets;

 

2.1.3.
all of the goodwill associated with the Transferee’s Business and/or any of the Transferred
Assets;

 

2.1.4.
all Documents that are primarily used or relate to the Transferee’s Business or any of the Transferred Assets;

 

2.1.5.
all other current assets of the Transferee’s Business.

 

Any
rights, assets, properties and business that fall within the above definition of Transferred Assets shall be deemed a Transferred
Asset, notwithstanding the failure to list the same on any of the aforementioned lists and schedules.

 

2.2.
Assumption of Liabilities. On the terms and subject to the conditions set forth in this Agreement, at the Closing, the
Transferee shall assume all liabilities related to or arise from the Transferred Assets, the Products and/or the Transferee’s
Business and/or the operation of the Transferee’s Business, including without limitation liabilities arising from the Transferred
Assets (the “Assumed Liabilities”).

 

    	 

    	 

    

 

2.3.
No Representations. The Transferred Assets are transferred by the Transferor on an “as is” basis, namely, their
state or condition on the date hereof and on the Closing Date, whether or not any fact, act or circumstance of any nature whatsoever
relating thereto is known, disclosed or discussed, and regardless of any investigation, inquiry or disclosure that was or could
have been made, and whether or not any fact or circumstance is different than expected by the Transferee, and without receiving
or relying on any representations or warranties with respect to such matters from the Transferor and its Representatives, except
for the Transferor’s title in the applicable Transferred Assets being on the Closing Date free and clear of Liens.

 

2.4.
Further Conveyances and Assumptions.

 

2.4.1.
From time to time following the Closing and without additional consideration to the Transferor, the Transferor and the Transferee
shall execute, acknowledge and deliver in a reasonably prompt manner, all such further deeds, agreements, instruments, conveyances,
notices, assumptions, releases and such other instruments, and shall take such further actions, in each case, as may be commercially
reasonably necessary or appropriate to assure fully to the Transferee and its respective successors or assigns, all of the properties,
rights, titles, interests, remedies, powers and privileges intended to be conveyed to the Transferee under this Agreement, including
with respect to the Transferred Assets, and to assure fully to the Transferor and its Affiliates, successors and assigns, the
assumption of the Assumed Liabilities, and to otherwise make effective the transactions contemplated hereby and thereby.

 

3.
LICENSES; CONSULTATION SERVICES;

 

3.1.
Back License. With respect to the patents included in Schedule 2.1(a) (the “Transferred IP”), Transferee
hereby grants Transferor a perpetual, transferable, worldwide, royalty free, sub-licensable license to access and use the Transferred
IP for the purpose of developing, marketing and sale of the Transferor’s Medigus Ultrasonic Surgical Endostapler (collectively,
the “License Back”).

 

3.2.
Patent License. 

 

3.2.1.
With respect to the patents included in Schedule 3.2 (the “Licensed IP”), Transferor hereby grants Transferee
a perpetual, non-exclusive, transferable, royalty free, license to access, use, improve, develop either by or on behalf of the
Transferee, market and sell the Licensed IP, including the right to any future versions, enhancements, improvements and derivative
works of the Licensed IP for the purpose of developing and commercializing the Products (collectively, the “License”).

 

3.2.2.
As a condition of the License, Transferor shall not sell, offer to sell or grant any ownership right in the Licensed IP to any
potential direct competitor of Transferee. For the avoidance of doubt, the License does not (and shall not be construed) to limit
or restrict the Transferor’s right to grant any additional licenses relating to the Licensed IP including to non-direct
competitors of Transferee.

 

3.3.
Consulting Services. Transferee shall provide Transferor consultancy and support services for no consideration, on matters
relating to the management, development, maintenance and commercialization of Transferor’s patent portfolio (the “Consulting
Services”). 

 

3.4.
Successors and Assigns. The terms and conditions of the License will bind and inure to the benefit of each of the Parties,
their successors and Affiliates. 

 

4.
CONSIDERATION; TAXES. 

 

4.1.
In consideration for the Transferred Assets and Assumed Liabilities Transferee issues Transferor [1,000,000] ordinary shares,
no par value each, of Transferee. 

 

4.2.
Any tax consequences arising from the sale and assignment or any other event or act hereunder, shall be borne solely by the Transferor.

 

    	 

    	 

    

 

5.
CLOSING

 

5.1.
Closing Date. Subject to the satisfaction or waiver of the conditions set forth in Section ‎6 hereof, the closing of
the transfer of the Transferred Assets and the assumption of the Assumed Liabilities (the “Closing”) shall
take place at the offices of Meitar, Liquornik, Geva, Leshem, Tal, Law Offices, at 10:00 a.m. (Israel time) on not later than
the second business day following the date on which the condition to Closing set forth in Section ‎6 is met or waived,
as applicable, unless another time or date, or both, are agreed by the Parties (the date on which the Closing occurs, the “Closing
Date”). The actions and occurrences to occur prior to or at the Closing shall be deemed to have occurred simultaneously
and no action shall be deemed to have been completed and no document or certificate shall be deemed to have been delivered, until
all actions are completed and all documents and certificates are delivered.

 

5.2.
Transferor’s Closing Deliverables. The Transferor shall deliver or shall cause to be delivered to the Transferee,
at or prior to the Closing:

 

5.2.1.
The Bill of Transfer, duly executed by the Transferor, in the form attached hereto as Schedule ‎5.2.1;

 

5.2.2.
Assignment deeds and powers of attorney with respect to any and all registrable Transferred Assets, and all the applications to
register any of the foregoing, in forms suitable for recordation in all jurisdictions, duly executed by the Transferor;

 

5.2.3.
Executed Transfer Letter for each one of the Transferred Employees.

 

5.3.
Transferee’s Closing Deliverables. The Transferee shall deliver or shall cause to be delivered to the Transferor,
at or prior to the Closing a counterpart of the documents referred to in Section ‎5.2 duly executed by the Transferee.

 

6.
ADDITIONAL COVENANTS AND AGREEMENTS.

 

6.1.
Intercompany Services. Following the Closing the Transferor shall provide the Transferee with certain services, including
but not limited to administrative and office space services. The Parties wish to set their responsibilities in this regard in
accordance with Appendix
A. 

 

6.2.
Employees.

 

6.2.1.
Promptly following the date hereof, the Transferee shall make an offer of continued employment (‘haavara beretzef’
in Hebrew), effective as of the Closing Date and contingent on the completion of the transactions contemplated hereunder, to the
employees agreed upon separately by the Parties to be fully countersigned by such employees (such form and any ancillary document
thereto, including waivers, shall be hereinafter referred to as the “Employee Offer”). Such employees who countersign
the Employee Offer and are transferred to Transferee at Closing are hereinafter referred to as “Transferred Employees”.

 

6.2.2.
(a) The Transferor hereby consents to the transfer at the Closing of each of the Transferred Employees to the Transferee and each
such employee shall become an employee of the Transferee at the Closing, and (b) the Transferor hereby undertakes to transfer
and assign to the Transferee for the benefit of the Transferred Employees (i) all education funds (‘keren hishtalmut’),
managers’ insurance policies (‘bituach menahalim’) and/or pension funds, severance pay funds and any
other funds and (ii) any accruals (prorated for partial month) for salary (including for the pay period in which the Closing occurs),
accrued annual vacation, recuperation fees entitlement, in each case of clauses (i) and (ii), that have been reserved or contributed
by the Transferor (whether required by applicable law, custom or agreement) with respect to any of such Transferred Employees
(the “Transferor Existing Funds”) and all of the Transferor’s rights with regard thereto. It is hereby
acknowledged and agreed that to the extent that any of the Transferor Existing Funds at Closing are not sufficient to cover all
such funds to which any Transferred Employee is entitled through the Closing Date (by applicable law, custom or agreement), the
Transferor shall transfer cash equal to the shortfall amount to the Transferor Existing Funds. Prior to the Closing, the Transferor
shall make (and the Transferee shall cooperate with the Transferor to the extent required) the appropriate filings with the ITA
for the transfer of the Transferor Existing Funds from the Transferor to the Transferee, and the Transferor shall submit, within
the appropriate time periods, all required documents to the Transferred Employees’ funds and insurance policies. At the
Closing or promptly thereafter (but not as a condition to Closing), the Transferor will transfer to Transferee all its title,
rights and interests in and to the Transferor Existing Funds.

 

6.2.3.
The Transferred Employees shall transfer to the Transferee, as applicable, with continuity of rights, and whilst taking their
term of employment with the Transferor in account for purposes of the calculation of their rights and entitlements.

 

    	 

    	 

    

 

6.2.4.
Notwithstanding any obligations of any Transferred Employee to the Transferor, all Transferred Employees (i) shall be permitted,
on and after the Closing Date, to engage in the Transferee’s Business, and (ii) shall be relieved and released from the
confidentiality and non-compete obligations owed to the Transferor solely to the extent required to perform the obligations and
duties under their respective employment or engagement agreements with the Transferee.

 

7.
CONDITION TO CLOSING

 

7.1.
Condition Precedent to the Obligations of Each Party. The respective obligations of each of the Transferee and the Transferor
to effect the Closing shall be subject to Transferor and Transferee obtaining the approval of the IIA to cancel the Prior Agreement.

 

8.
TERMINATION OF AGREEMENT.

 

8.1.
This Agreement may be terminated prior to the Closing by mutual written consent of the Transferee and the Transferor. In the event
of termination, each of the Parties shall be relieved of their duties and obligations arising under this Agreement after the date
of such termination and such termination shall be without any liability to any of the Parties and their respective Representatives.

 

9.
MISCELLANEOUS.

 

9.1.
Entire Agreement. This Agreement (including the schedules and exhibits hereto) represents the entire understanding and
agreement between the Parties hereto with respect to the subject matter hereof and supersede all prior agreements and understandings,
both written and oral among the Parties hereto with respect to the subject matter hereof. For the avoidance of doubt, the asset
transfer agreement by and between the Parties entered as of March 14, 2019, as amended thereafter on July 21, 2019 is hereby null
and void. Notwithstanding the above, the asset transfer agreement between the parties, dated as of September 3, 2019, effective
as of May 28, 2019 shall remain in full force and effect. 

 

9.2.
Amendments and Waivers. This Agreement may be amended, supplemented or changed, and any provision hereof can be waived,
only by written instrument signed by the parties hereto, or in case of a waiver by the party against whom enforcement of any such
amendment, supplement, modification or waiver is sought. No action taken pursuant to this Agreement, including without limitation,
any investigation by or on behalf of any party, shall be deemed to constitute a waiver by the party taking such action of compliance
with any representation, warranty, covenant or agreement contained herein. The waiver by any party hereto of a breach of any provision
of this Agreement shall not operate or be construed as a further or continuing waiver of such breach or as a waiver of any other
or subsequent breach. No failure on the part of any party to exercise, and no delay in exercising, any right, power or remedy
hereunder shall operate as a waiver thereof, nor shall any single or partial exercise of such right, power or remedy by such party
preclude any other or further exercise thereof or the exercise of any other right, power or remedy.

 

9.3.
No Third Party Beneficiaries; Assignment. Nothing in this Agreement shall create or be deemed to create any third party
beneficiary rights in any person or entity not a party to this Agreement, but other than rights expressly granted to Representatives
of a party hereunder. No assignment of this Agreement or of any rights or obligations hereunder may be made (by operation of law
or otherwise) by the Transferor or the Transferee without the prior written consent of the other party hereto and any attempted
assignment without the required consents shall be void; provided, however, that after Closing, either party may assign this Agreement
and any or all rights or obligations hereunder to any Affiliate.

 

9.4.
Governing Law; Jurisdiction. This Agreement shall be governed by and construed in accordance with the laws of the State
of Israel, without giving effect to the rules of conflict of laws thereof. Each of the parties hereto irrevocably consents to
the exclusive jurisdiction and venue of any competent court located in Tel Aviv-Jaffa, Israel, in connection with any matter based
upon or arising out of this Agreement or the matters contemplated herein, agrees that process may be served upon them in any manner
authorized by the laws of the State of Israel for such persons and waives and covenants not to assert or plead any objection which
they might otherwise have to such jurisdiction and such process.

 

9.5.
Severability. If any term or other provision of this Agreement is invalid, illegal, or incapable of being enforced by any
law or public policy, all other terms or provisions of this Agreement shall nevertheless remain in full force and effect so long
as the economic or legal substance of the transactions contemplated hereby is not affected in any manner materially adverse to
any party. Upon such determination that any term or other provision is invalid, illegal, or incapable of being enforced, the parties
hereto shall negotiate in good faith to modify this Agreement so as to effect the original intent of the parties as closely as
possible in an acceptable manner in order that the transactions contemplated hereby are consummated as originally contemplated
to the greatest extent possible.

 

9.6. Counterparts.
This Agreement may be executed in one or more counterparts, each of which shall be deemed an original and enforceable
against the parties actually executing such counterpart, and all of which together shall be considered one and the same
agreement, it being understood that all parties need not sign the same counterpart. The exchange of an executed Agreement (in
counterparts or otherwise) by facsimile transmission or by electronic delivery in .pdf format or the like shall be sufficient
to bind the parties to the terms and conditions of this Agreement, as an original.

 

-
Signature Pages Follow -

 

    	 

    	 

    

 

IN
WITNESS WHEREOF, the parties hereto have caused this AMENDED AND RESTATED ASSET TRANSFER AGREEMENT to be executed by their respective
officers thereunto duly authorized, as of the date first written above.

 

	Medigus
    Ltd.	 	ScoutCam Ltd.
	 	 	 	 	 
	By:	/s/
    Liron Carmel / /s/ Tanya Yosef	 	By:	/s/
    Benad Goldwasser / /s/ Yaron Silberman
	Name:	Liron
    Carmel / Tanya Yosef	 	Name:	Benad
    Goldwasser / Yaron Silberman
	Title:	Chief
    Executive Officer / Chief Financial Officer	 	Title:	Chairman
    of the Board / Chief Executive Officer

 

    	 

    	 

    

 

Schedule
2.1

 

List
of Transferred Assets

 

[**]

 

    	 

    	 

    

 

Schedule
3.2

 

List
of Licensed Assets

 

[**]

 

    	 

    	 

    

 

Schedule
5.2.1

 

BILL
OF TRANSFER

 

THIS
BILL OF TRANSFER (this “Bill”) is made as of March 1, 2019 by and between Medigus Ltd. (“Transferor”)
and ScoutCam Ltd. (“Transferee”). Unless otherwise defined herein, capitalized terms used herein shall have
the meaning ascribed to them in that certain Amended and Restated Asset Transfer Agreement by and between Transferor and Transferee
(the “Amended and Restated Asset Transfer Agreement”).

 

W
I T N E S S E T H:

 

WHEREAS
Pursuant to the Amended and Restated Asset Transfer Agreement, Transferor has agreed to convey, assign, transfer and deliver
to Transferee all right, title and interest of Transferor in and to all of the Transferred Assets; and

 

WHEREAS
Pursuant to due authorization, Transferor is executing and delivering this Bill for the purpose of conveying, assigning, transferring
and delivering to Transferee all of its right, title and interest in and to the Transferred Assets.

 

NOW,
THEREFORE, the parties hereto, intending to be legally bound hereby, hereby agree as follows:

 

	1)	Transferor hereby
    transfers to Transferee and its successors and assigns the Transferred Assets and any and all legal and equitable interests
    therein, and Transferee hereby accepts such Transferred Assets, all in accordance with the terms and subject to the conditions
    set forth in the Amended and Restated Asset Transfer Agreement. Neither the making nor the acceptance of this Bill shall amend,
    restrict or otherwise modify any of the terms of the Amended and Restated Asset Transfer Agreement or the rights and obligations
    of the parties thereunder.
	 	 
	2)	Upon the transfer
    contemplated hereunder, Transferee shall have and hold the Transferred Assets, forever, to its own proper use and behalf.
	 	 
	3)	Upon the transfer
    contemplated hereunder, Transferee shall acquire the right to collect, assert, and enforce all claims, causes of action, rights
    of recovery and rights of set off, pertaining to or arising out of the Transferred Assets whether before or after the Closing
    Date, including without limitations, the right to sue, to enforce, and collect damages.
	 	 
	4)	Transferor shall
    execute, acknowledge and deliver in a reasonably prompt manner, all such further conveyances, notices, assumptions, releases
    and such other instruments, and shall take such further actions, in each case, as may be reasonably necessary or appropriate
    to assure fully to Transferee and its respective successors or assigns, all of the properties, rights, titles, interests,
    remedies, powers and privileges intended to be conveyed to Transferee with respect to the Transferred Assets, and to otherwise
    make effective the transactions contemplated hereby.
	 	 
	5)	Transferor hereby
    appoints Transferee (with a right of reappointment), and its designees, representatives and the respective successors and
    assigns of the foregoing, the true and lawful attorney Transferee, in the name of Transferee or in the name of Transferor,
    to demand and receive any and all interests in the assets hereby transferred; to give releases and acquittances for or in
    respect of the same or any part thereof; and to collect, assert or enforce any claim, right or title hereby assigned; in each
    case that Transferee, or its successors and assigns, shall deem necessary or advisable. Transferor hereby declares that the
    foregoing powers are coupled with an interest and shall be irrevocable.

 

    	 

    	 

    

 

	6)	This Bill, together with the other applicable provisions
    of the Amended and Restated Asset Transfer Agreement and the Transaction Documents, sets forth the entire understanding and
    agreement between the parties hereto with respect to the subject matter hereof and supersedes all prior agreements or understandings
    among the parties hereto with respect to the subject matter hereof. Notwithstanding the above, the asset transfer agreement
    between the parties, dated as of September 3, 2019, effective as of May 28, 2019 shall remain in full force and effect.
    In the event that any of the terms of this Bill conflict with or contradict any of the terms of the Amended and Restated
    Asset Transfer Agreement, the terms of the Amended and Restated Asset Transfer Agreement shall prevail. All matters relating
    to the transfer of the Transferred Assets to Transferee and not expressly regulated hereunder, shall be deemed to be regulated
    by the Amended and Restated Asset Transfer Agreement.
	 	 
	7)	This Bill shall be governed by and construed in accordance
    with the laws of the State of Israel, without giving effect to the rules of conflict of laws thereof. Each of the parties
    hereto irrevocably consents to the exclusive jurisdiction and venue of any competent court located in Tel Aviv-Jaffa, Israel,
    in connection with any matter based upon or arising out of this Bill or the matters contemplated herein, agrees that process
    may be served upon them in any manner authorized by the laws of the State of Israel for such persons and waives and covenants
    not to assert or plead any objection which they might otherwise have to such jurisdiction and such process.
	 	 
	8)	This Bill is being executed by Transferor and Transferee
    and shall be binding upon, inure to the benefit of, and be enforceable by, each of Transferor and Transferee, and their respective
    successors and assigns, for the uses and purposes above set forth and referred to, and shall be effective as of the date hereof.
	 	 
	9)	This Bill may be amended, supplemented or changed, and any
    provision hereof can be waived, only by written instrument signed by the parties hereto, or in case of a waiver by the party
    against whom enforcement of any such amendment, supplement, modification or waiver is sought.
	 	 
	10)	This Bill may be executed in one or more counterparts, each
    of which shall be deemed an original and enforceable against the parties hereto, and all of which together shall be considered
    one and the same agreement, it being understood that all parties need not sign the same counterpart. The exchange of an executed
    Bill (in counterparts or otherwise) by facsimile transmission or by electronic delivery in .pdf format or the like shall be
    sufficient to bind the parties to the terms and conditions of this Bill, as an original.

[**]

 

-
Signature Pages Follow -

 

    	 

    	 

    

 

	Medigus
    Ltd.	 	ScoutCam
    Ltd.
	 	 	 	 	 
	By:	/s/
    Liron Carmel	 	By:	/s/
    Benad Goldwasser
	Name:	Liron
    Carmel	 	Name:	Benad
    Goldwasser
	Title:	Chief
    Executive Officer	 	Title:	Chairman
    of the Board

 

	By:	/s/
    Tanya Yosef	 	By:	/s/
    Yaron Silberman
	Name:	Tanya
    Yosef	 	Name:	Yaron
    Silberman
	Title:	Chief
    Financial Officer	 	Title:	Chief
    Executive Officer

 

-
Signature Pages Follow -

 

    	 

    	 

    

 

	Medigus
    Ltd.	 	ScoutCam
    Ltd.
	 	 	 	 	 
	By:	/s/
    Liron Carmel	 	By:	/s/
    Benad Goldwasser
	Name:	Liron
    Carmel	 	Name:	Benad
    Goldwasser
	Title:	Chief
    Executive Officer	 	Title:	Chairman
    of the Board

 

	By:	/s/
    Tanya Yosef	 	By:	/s/
    Yaron Silberman
	Name:	Tanya
    Yosef	 	Name:	Yaron
    Silberman
	Title:	Chief
    Financial Officer	 	Title:	Chief
    Executive Officer

 

    	 

    	 

    

 

Appendix
A

 

[**]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00303-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00303-of-00352.parquet"}]]